Glaxosmithkline (GSK)

 

Latest News

GSK and Innoviva report positive COPD results

GlaxoSmithKline and Innoviva have announced positive headline results from an IMPACT which showed that single inha...

Positive IMPACT results for Trelegy in COPD

RNS Number: 2534R GlaxoSmithKline PLC 20 September 2017 Issued: 20 September 2017, London UK - LSE Announcement GSK and Innoviva report positive headline results from IMPACT study showing single inhaler triple therapy Trelegy Ellipta reduced COPD exacerbations Trelegy Ellipta met study primary endpoint demonstrating reduction in exacerbations c...

FTSE gains supported by BP, Shell and sterling retreat

Oil giants BP (BP.) and Royal Dutch Shell (RDSB) boosted the FTSE 100 thanks to stable oil prices. Brent crude oil advanced...

Trelegy Ellipta: FDA approval in COPD received

RNS Number: 0979R GlaxoSmithKline PLC 18 September 2017 Issued: 18 September 2017, London UK - LSE Announcement Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the...

All News

DateHeadlineSource
20-09-17GSK and Innoviva report positive COPD results StockMarketWire
20-09-17Positive IMPACT results for Trelegy in COPDRNS
19-09-17FTSE gains supported by BP, Shell and sterling retreatStockMarketWire
19-09-17Trelegy Ellipta: FDA approval in COPD receivedRNS
18-09-17Investors to receive £8.2 billion dividend windfallInteractive Investor
15-09-17Trelegy Ellipta: positive opinion from CHMP EuropeRNS
14-09-17FDA committee recommends GSK shingles vaccine StockMarketWire
14-09-17Unanimous FDA approval for Shingrix in over 50sRNS
13-09-17Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLCStockMarketWire
12-09-17Director/PDMR ShareholdingRNS
12-09-17GSK: phase III results on mepo in COPD in NEJMRNS
11-09-17GSK announces positive results from SLS lung studyStockMarketWire
11-09-17GSK announce positive results from SLS lung studyRNS
06-09-17Director/PDMR ShareholdingRNS
06-09-17Broker Forecast - Credit Suisse issues a broker note on GlaxoSmithKline PLCStockMarketWire
04-09-17A small-cap pharma still smashing City forecastsInteractive Investor
01-09-17Total Voting RightsRNS
30-08-17Stocks to buy and sell as summer endsInteractive Investor
24-08-17Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLCStockMarketWire
23-08-17Dogs of the Footsie: Thrashing FTSE 100 at halfway stageMoney Observer
22-08-17Stockwatch: Is this a coiled spring or a falling knife?Interactive Investor
17-08-17Down 50% since March but still a 'buy'Interactive Investor
10-08-17Director/PDMR ShareholdingRNS
10-08-17Director/PDMR ShareholdingRNS
09-08-17Broker Forecast - Berenberg issues a broker note on GlaxoSmithKline PLCStockMarketWire
07-08-17Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLCStockMarketWire
04-08-17Base prospectus re ?15bn EMTN programmeRNS
01-08-17Total Voting RightsRNS
28-07-17Share of the Week: This healthcare small-cap could trebleInteractive Investor
28-07-17Director/PDMR ShareholdingRNS
28-07-17Director/PDMR ShareholdingRNS
26-07-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-07-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-07-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-07-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-07-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
26-07-17Director/PDMR ShareholdingRNS
26-07-17Director/PDMR Shareholding - ReplacementRNS
26-07-17Half-year ReportRNS
25-07-17ViiV receives results from NEAT studyStockMarketWire

RSS feeds

  • Editorial news feed for LSE:GSK Editorial
  • Regulatory news feed for LSE:GSK Regulatory